Vimarsana
Biggest News Aggregation in the World

Brian Goff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Brian Goff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Brian Goff Today - Breaking & Trending Today

DW DW News - News November 15, 2017 - Vimarsana News

DW DW News - News November 15, 2017

Saying more action is needed if the world is to meet Global Warming targets also coming up. Flash floods roared through two towns near the greek capital athens taking residents by surprise a living a trail of destruction at least fourteen people are dead. Tanks on the streets of horror and veteran leader Robert Mugabe under house arrest the army denies it staging a coup but uncertainty about the situation is growing. Plus a resoundingly yes in australia to Marriage Equality of belief in the gay and Lesbian Community as more than sixty percent of poll respondents vote to legalize same sex marri...

Agios sells vorasidenib royalty rights to Royalty Pharma for $905M - Vimarsana News

Agios sells vorasidenib royalty rights to Royalty Pharma for $905M

Vorasidenib, which treats IDH-mutant diffuse glioma, showed efficacy in data released last year.

Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal - Vimarsana News

Agios Stock Poised To Break Out On $905 Million Brain Cancer Deal

Agios agreed Tuesday to sell its 15% royalty in a brain cancer drug for $905 million upfront. Agios stock broke out at the open.

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute - Vimarsana News

Longwood Healthcare Leaders Spring MIT to Convene Life Science Thought Leaders at MIT Koch Institute

BOSTON, MA / ACCESSWIRE / May 23, 2024 / Longwood Fund, an early-stage life science venture firm, will convene top biopharmaceutical leaders for two days of discussion and networking at its annual Longwood

Agios Pharmaceuticals (NASDAQ:AGIO) Announces Quarterly Earnings Results - Vimarsana News

Agios Pharmaceuticals (NASDAQ:AGIO) Announces Quarterly Earnings Results

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) issued its quarterly earnings data on Thursday. The biopharmaceutical company reported ($1.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.64) by $0.19, Briefing.com reports. Agios Pharmaceuticals had a negative return on equity of 39.74% and a negative net margin of 1,199.26%. The company […]